Stryker (SYK) AGM 2026 summary
Event summary combining transcript, slides, and related documents.
AGM 2026 summary
6 May, 2026Opening remarks and agenda
Meeting commenced with reminders about forward-looking statements and non-GAAP measures, and confirmation of quorum and proper notice to shareholders.
Recognition of long-serving leaders and introduction of current board members and executive team.
Shareholder proposals
Three proposals presented: election of 10 directors, ratification of Ernst & Young as auditor for 2026, and advisory vote on executive compensation.
Voting conducted online, with results announced later in the meeting.
Financial performance review
Surpassed $25 billion in sales in 2025, maintaining double-digit organic sales growth.
Category leadership across business segments, with recent creation of Ortho Tech division.
Partial view of Summaries dataset, powered by Quartr API
Latest events from Stryker
- Q2 sales rose 9.4% and adjusted EPS climbed 17.9%, driven by strong recovery and volume growth.SYK
Q2 2026 - Full-year outlook remains strong, with robust recovery and innovation driving growth.SYK
Bank of America Global Healthcare Conference 2026 - Cyber incident pressured Q1 margins, but sales rose 2.6% and full-year guidance is reaffirmed.SYK
Q1 2026 - Definitive additional proxy materials filed for shareholder voting, with no fee required.SYK
Proxy filing - Double-digit sales and EPS growth in 2025, with robust 2026 outlook and margin expansion.SYK
Q4 2025 - Q3 net sales up 11.9% and adjusted EPS up 16.7%, with strong 2024 outlook.SYK
Q3 2024 - Growth driven by innovation, robotics, and portfolio shifts, with margin and global expansion in focus.SYK
Citi’s 2025 Medtech and Life Sciences Access Day - Raised 2025 outlook after double-digit organic growth and Inari acquisition, despite margin pressure.SYK
Q1 2025 - Double-digit organic growth, margin expansion, and strategic moves set up a strong 2025 outlook.SYK
Q4 2024